secwatch / observer
8-K filed Apr 27, 2026 23:59 UTC CIK 0001178879
m_and_a confidence high sentiment neutral materiality 1.00

Amicus Therapeutics acquired by BioMarin for $14.50 per share in all-cash merger

AMICUS THERAPEUTICS, INC.

item 1.02item 2.01item 3.01item 3.03item 5.01item 5.02item 5.03item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Margaret G. McGlynn

Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed

Eiry W. Roberts

Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Appointed

Brian Mueller

Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Filed
Apr 27, 2026 23:59 UTC
The directors of Merger Sub immediately prior to the Effective Time were Eric Davis and Brian Mueller.
Departed

Ellen S. Rosenberg

Other Named Officer
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis (President and Secretary), Brian Mueller (Treasurer)
Filed
Apr 27, 2026 23:59 UTC
all executive officers of the Company immediately prior to the Effective Time (Bradley L. Campbell, Simon Harford, Ellen S. Rosenberg, David M. Clark and Jeffrey P. Castelli) ceased to be executive officers of the Surviving Corporation.
Departed

Burke W. Whitman

Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Appointed

Eric Davis

President and Secretary
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Filed
Apr 27, 2026 23:59 UTC
Eric Davis, as President and Secretary of Merger Sub immediately prior to the Effective Time, became President and Secretary of the Surviving Corporation
Departed

Simon Harford

Other Named Officer
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis (President and Secretary), Brian Mueller (Treasurer)
Filed
Apr 27, 2026 23:59 UTC
all executive officers of the Company immediately prior to the Effective Time (Bradley L. Campbell, Simon Harford, Ellen S. Rosenberg, David M. Clark and Jeffrey P. Castelli) ceased to be executive officers of the Surviving Corporation.
Departed

Michael A. Kelly

Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed

Bradley L. Campbell

Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed

Craig A. Wheeler

Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed

Michael G. Raab

Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed

Lynn D. Bleil

Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed

Glenn P. Sblendorio

Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis, Brian Mueller
Filed
Apr 27, 2026 23:59 UTC
each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed

Jeffrey P. Castelli

Other Named Officer
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis (President and Secretary), Brian Mueller (Treasurer)
Filed
Apr 27, 2026 23:59 UTC
all executive officers of the Company immediately prior to the Effective Time (Bradley L. Campbell, Simon Harford, Ellen S. Rosenberg, David M. Clark and Jeffrey P. Castelli) ceased to be executive officers of the Surviving Corporation.
Appointed

Eric Davis

Director
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Filed
Apr 27, 2026 23:59 UTC
The directors of Merger Sub immediately prior to the Effective Time were Eric Davis and Brian Mueller.
Departed

David M. Clark

Other Named Officer
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis (President and Secretary), Brian Mueller (Treasurer)
Filed
Apr 27, 2026 23:59 UTC
all executive officers of the Company immediately prior to the Effective Time (Bradley L. Campbell, Simon Harford, Ellen S. Rosenberg, David M. Clark and Jeffrey P. Castelli) ceased to be executive officers of the Surviving Corporation.
Appointed

Brian Mueller

Treasurer
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Filed
Apr 27, 2026 23:59 UTC
Brian Mueller, as Treasurer of Merger Sub immediately prior to the Effective Time, became Treasurer of the Surviving Corporation
Departed

Bradley L. Campbell

Other Named Officer
AMICUS THERAPEUTICS, INC.
Effective
2026-04-27
Successor
Eric Davis (President and Secretary), Brian Mueller (Treasurer)
Filed
Apr 27, 2026 23:59 UTC
all executive officers of the Company immediately prior to the Effective Time (Bradley L. Campbell, Simon Harford, Ellen S. Rosenberg, David M. Clark and Jeffrey P. Castelli) ceased to be executive officers of the Surviving Corporation.
Source: SEC EDGAR
accession 0001140361-26-016968

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.